Back
Adaptimmune Therapeutics PLC Vs. Biodexa Pharmaceuticals Plc Industry Stock Comparison
Buy
64
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.19
Seasonality Move:
-1.36%
Sell
44
BDRX
Biodexa Pharmaceuticals Plc
Last Price:
1.23
Seasonality Move:
-23.05%
Buy
64
Adaptimmune Therapeutics PLC (ADAP)
is a Buy
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.24. The Score for ADAP is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- ADAP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Biodexa Pharmaceuticals Plc (BDRX)
is a Sell
Is Biodexa Pharmaceuticals Plc a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals Plc [BDRX] share price is $1.13. The Score for BDRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.24
The current trend is relatively stagnant and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals Plc's stock price today?
-
The Biodexa Pharmaceuticals Plc share price today is $1.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BDRX is experiencing slight selling pressure.
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 55.23 | Buy |
| Chaikin Money Flow: | 809941 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.2) | Buy |
| Bollinger Bands (100): | (0.85 - 1.47) | Buy |
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 52.93 | Buy |
| Chaikin Money Flow: | 9256 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.79 - 1.21) | Buy |
| Bollinger Bands (100): | (0.93 - 1.99) | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.15 | Buy |
| 20-day SMA: | 1.12 | Buy |
| 50-day SMA: | 1.29 | Sell |
| 200-day SMA: | 0.91 | Buy |
| 8-day EMA: | 1.16 | Buy |
| 20-day EMA: | 1.16 | Buy |
| 50-day EMA: | 1.2 | Buy |
| 200-day EMA: | 1.09 | Buy |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.03 | Buy |
| 20-day SMA: | 1.03 | Buy |
| 50-day SMA: | 1.08 | Buy |
| 200-day SMA: | 2.93 | Sell |
| 8-day EMA: | 1.06 | Buy |
| 20-day EMA: | 1.06 | Buy |
| 50-day EMA: | 1.17 | Sell |
| 200-day EMA: | 38.21 | Sell |
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.08 per share.
Biodexa Pharmaceuticals Plc Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.03 per share.
Adaptimmune Therapeutics PLC Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biodexa Pharmaceuticals Plc Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||